©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Artif Intell Gastroenterol. Jul 28, 2020; 1(1): 5-11
Published online Jul 28, 2020. doi: 10.35712/aig.v1.i1.5
Published online Jul 28, 2020. doi: 10.35712/aig.v1.i1.5
Application of artificial intelligence in hepatology: Minireview
Ryota Masuzaki, Tatsuo Kanda, Reina Sasaki, Naoki Matsumoto, Kazushige Nirei, Masahiro Ogawa, Mitsuhiko Moriyama, Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo 173-8610, Japan
Author contributions: Masuzaki R and Kanda T contributed to the conceptualization; Masuzaki R contributed to original draft preparation; Kanda T contributed to reviewing and editing; Sasaki R, Matsumoto N, Ogawa M, Nirei K, and Moriyama M contributed to the supervision of this study; Moriyama M contributed to the project administration; all authors have read and agreed to the submitted version of the manuscript.
Conflict-of-interest statement: There is no conflict of interest.
Corresponding author: Tatsuo Kanda, MD, PhD, Associate Professor, Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchikami-cho, Itabashi-ku, Tokyo 173-8610, Japan. kanda2t@yahoo.co.jp
Received: May 28, 2020
Peer-review started: May 28, 2020
First decision: June 13, 2020
Revised: June 23, 2020
Accepted: July 16, 2020
Article in press: July 16, 2020
Published online: July 28, 2020
Processing time: 60 Days and 0.1 Hours
Peer-review started: May 28, 2020
First decision: June 13, 2020
Revised: June 23, 2020
Accepted: July 16, 2020
Article in press: July 16, 2020
Published online: July 28, 2020
Processing time: 60 Days and 0.1 Hours
Core Tip
Core tip: Artificial intelligence (AI) plays a significant role in our daily life and the research field. In this review, we summarized the recent findings of AI concerning hepatology. AI will be useful in the detection and diagnosis of liver tumors and the discrimination of high-risk patients for hepatic decompensation and hepatocellular carcinoma development. Furthermore, AI can be utilized in basic research, such as in the interpretation of genomics, transcriptomics, and proteomics. We hope that this review will help in future management.